The human papillomavirus (HPV) 16 E6 oncoprotein leads to an increase in gene expression of the angiogenic switch molecule FGF-BP in non-immortalizedhuman keratinocytes
H. Stoppler et al., The human papillomavirus (HPV) 16 E6 oncoprotein leads to an increase in gene expression of the angiogenic switch molecule FGF-BP in non-immortalizedhuman keratinocytes, ONCOGENE, 20(50), 2001, pp. 7430-7436
Fibroblast growth, factor binding protein (FGF-BP) is a secreted protein th
at binds, FGF-1 and FGF-2 and is involved in mobilization and activation of
FGFs from the extracellular matrix. FGF-BP overexpression as, well as ribo
zyme-mediated reduction of endogenous FGF-BP revealed that FGF-BP can be ra
te-limiting for tumor growth and angiogenesis. Recent studies showed that F
GF-BP expression is up-regulated during early phases of tumorigenesis, indi
cating that the role of FGF-BP in angiogenesis is a critical early step in
the development and progression of tumors.. Human papillomavirus type, 16 (
HPV 16) is highly associated with the development of anogenital cancers. He
re we demonstrate that the stable expression of the E6 oncogene of HPV 16 l
eads to an activation of the FGF-BP promoter in primary human foreskin kera
tinocytes (one of the natural host cells of these viruses). This is associa
ted with, an increase in the steady state levels, of FGF-BP mRNA and FGF-BP
protein in cells stably expressing E6. Transient E6 expression revealed th
at the observed activation of the FGF-BP promoter by the viral oncogene is,
an early process which is. independent from immortalization/transformation
, events in the cells.